2024 Annual Report
I’m proud to share with you TAG’s 2024 Annual Report. Last year already seems long ago with all the attacks on research and health care, domestic and international, which are currently taking place under the new administration...
Brick by Brick: A Brief Guide to Protecting Your Community’s Health with Direct Action
TAG's Senior TB Project Associate, Erin McConnell, created this 'zine about TAG for Pride 2025. It's about fighting back, and goes over current threats, action items, and action steps on how to show up.
Ways You Can Help TAG
Become a Monthly Donor Become one of our community of dedicated supporters by becoming a monthly donor to TAG. Your recurring contribution provides steady support for critical programs, groundbreaking research, and advocacy efforts to combat HIV, hepatitis C, and tuberculosis…
NIH Advocacy Toolkit for HIV & TB Researchers
The Research Matters Advocacy Toolkit is a vital resource for researchers committed to advancing health equity and biomedical advocacy.
Hearing on Biomedical Research – Keeping America’s Edge in Innovation
Treatment Action Group (TAG) is issuing an urgent call to protect the integrity of biomedical research and public health.
Magic Mountains of Debt: Sovereign Debt Crises as Critical Barriers to Ending TB and Investing in Sustainable Development Goals
TAG’s Magic Mountains of Debt: Sovereign Debt Crises as Critical Barriers to Ending TB and Investing in Sustainable Development Goals analyzes the impact of sovereign debt in depressing investments in TB programs, services, and R&D in high-TB burden nations.
Scoping Community Interventions to Support New TB Vaccine Introduction: From Grassroots Partnerships to Global Policymaking
Survey now extended until April 24! TAG, with support from Wellcome, is conducting a scoping exercise of community partners and interventions to support new TB vaccine readiness.
An Activist’s Guide to Shorter Treatment for Drug-Resistant Tuberculosis
The new 2025 update of An Activist’s Guide to Shorter Treatment for Drug-Resistant Tuberculosis lays out what community advocates need to know about WHO-recommended regimens for drug-resistant TB.
Treatment Action Group Opposes the Nomination of Dr. Jay Bhattacharya for Director of the U.S. National Institutes of Health
The nomination of Dr. Jay Bhattacharya for Director of the United States National Institutes of Health (NIH) continues the pattern of un- and under-qualified nominees put forward by the current administration.
TAG Fiercely Condemns the New Administration’s War on Science
Treatment Action Group (TAG) is disgusted and appalled by the new presidential administration’s flagrant attack on science.